Hepcidin: a promising marker for differential diagnosis of anemia and macrophage activation syndrome in children with juvenile idiopathic arthritis
- 作者: Egorov A.S.1, Fedorova E.V.1, Chasnyk V.G.1, Kostik M.M.1, Snegireva L.S.1, Kalashnikova O.V.1, Dubko M.F.1, Masalova V.V.1, Likhacheva T.S.1
-
隶属关系:
- Saint Petersburg State Pediatric Medical University
- 期: 卷 5, 编号 4 (2014)
- 页面: 42-47
- 栏目: Articles
- URL: https://journals.eco-vector.com/pediatr/article/view/1162
- DOI: https://doi.org/10.17816/PED5442-47
- ID: 1162
如何引用文章
详细
全文:
作者简介
Andrey Egorov
Saint Petersburg State Pediatric Medical University
Email: egorov.doc@gmail.com
MD, Research Fellow, Chair of Hospital Pediatrics
Elena Fedorova
Saint Petersburg State Pediatric Medical University
Email: detymedic@mail.ru
MD, Research Fellow, Chair of Hospital Pediatrics
Vyacheslav Chasnyk
Saint Petersburg State Pediatric Medical University
Email: chasnyk@gmail.com
MD, PhD, Dr Med Sci, Professor, Head of the Department of Hospital Pediatrics
Mikhail Kostik
Saint Petersburg State Pediatric Medical University
Email: mikhail.kostik@gmail.com
MD, PhD, Associate Professor, Chair of Hospital Pediatrics
Ludmila Snegireva
Saint Petersburg State Pediatric Medical University
Email: l.s.snegireva@mail.ru
MD, Department of Pediatrics N 3
Olga Kalashnikova
Saint Petersburg State Pediatric Medical University
Email: koira7@yandex.ru
MD, PhD, Associate Professor, Chair of Hospital Pediatrics
Margarita Dubko
Saint Petersburg State Pediatric Medical University
Email: andrq@rambler.ru
MD, PhD, Associate Professor, Chair of Hospital Pediatrics
Vera Masalova
Saint Petersburg State Pediatric Medical University
Email: masalova.vera@gmail.com
MD, Research Fellow, Chair of Hospital Pediatrics
Tatyana Likhacheva
Saint Petersburg State Pediatric Medical University
Email: tatianasl@list.ru
MD, Research Fellow, Chair of Hospital Pediatrics
参考
- Yegorov A.S., Fedorova E. V. Rasprostranennost anemii u patsiyentov s yuvenilnym revmatoidnym artritom [The prevalence of anemia in patients with juvenile rheumatoid arthritis]. VII Vserossiyskaya konferentsiya “Revmatologiya v realnoy klinicheskoy praktike”: sbornik materialov konferentsii. Vladimir. 2012: 21.
- Bijlsma J. W., Jacobs J. W. Methotrexate: still the anchor drug in RA treatment. Joint Bone Spine. 2009; 76 (5): 452-4.
- Cartwright G. E., Wintrobe M. M. The anemia of infection. A review. Adv Intern Med. 1952; 5: 165-226.
- Donovan A., Lima C. A., Pinkus J. L., Pinkus G. S., Zon L. I., Robine S., Andrews N. C. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 2005; 1 (3): 191-200.
- Doyle M. K., Rahman M. U., Han C., Han J., Giles J., Bingham C. O., Bathon J. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials. Semin Arthritis Rheum. 2009; 39 (2): 123-31.
- Furst D. E., Chang H., Greenberg J. D., Ranganath V. K., Reed G., Ozturk Z. E., Kremer J. M. Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: evidence from the CORRONA registry. Clin Exp Rheumatol. 2009; 27 (4): 560-6.
- Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003; 102 (3): 783-8.
- Genovese M. C., McKay J. D., Nasonov E. L., Mysler E. F., da Silva N. A., Alecock E., Woodworth T., Gomez-Reino J. J. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis Rheum. 2008; 58 (10): 2968-80.
- Han C., Rahman M. U., Doyle M. K., Bathon J. M., Smolen J., Kavanaugh A., Westhovens R., St Clair E. W., Baker D., Bala M. Association of anemia and physical disability among patients with rheumatoid arthritis. J Rheumatol. 2007; 34 (11): 2177-82.
- Jayaranee S., Sthaneshwar P., Sokkalingam S. Serum prohepcidin concentrations in rheumatoid arthritis. Pathology. 2009;41 (2):178-82.
- Koca S. S., Isik A., Ustundag B., Metin K., Aksoy K. Serum pro-hepcidin levels in rheumatoid arthritis and systemic lupus erythematosus. Inflammation. 2008; 31 (3): 146-53.
- Krause A., Neitz S., Mägert H. J., Schulz A., Forssmann W. G., Schulz-Knappe P., Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000; 480 (2-3): 147-50.
- Maini R. N., Taylor P. C., Szechinski J., Pavelka K., Bröll J., Balint G., Emery P., Raemen F., Petersen J., Smolen J., Thomson D., Kishimoto T. CHARISMA Study Group. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum. 2006; 54 (9): 2817-29.
- Masson C. J. Rheumatoid anemia Rev. Joint Bone Spine. 2011; 78: 131-37.
- Means R. T. Jr. Hepcidin and anaemia. Blood Rev. 2004; 18 (4): 219-25.
- Means R. T. Jr. Recent developments in the anemia of chronic disease. Curr Hematol Rep. 2003; 2 (2): 116.
- Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B. K., Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004; 113 (9): 1271-6.
- Ou L. S., See L. C., Wu C. J., Kao C. C., Lin Y. L., Huang J. L. Association between serum inflammatory cytokines and disease activity in juvenile idiopathic arthritis. Clin Rheumatol. 2002; 21 (1): 52-6.
- Park C. H., Valore E. V., Waring A. J., Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. The Journal of Biological Chemistry. 2001; 276 (11): 7806-10.
- Peslova G., Petrak J., Kuzelova K., Hrdy I., Halada P., Kuchel P. W., Soe-Lin S., Ponka P., Sutak R., Becker E., Huang M. L., Suryo Rahmanto Y., Richardson D. R., Vyoral D. Hepcidin, the hormone of iron metabolism, is bound specifically to alpha-2-macroglobulin in blood. Blood. 2009; 113 (24): 6225-36.
- Rivera S., Nemeth E., Gabayan V., Lopez M. A., Farshidi D., Ganz T. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood. 2005; 106 (6): 2196-9.
- Wilson A., Yu H. T., Goodnough L. T., Nissenson A. R. Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am J Med. 2004; 116 (7A): 50-7.
- Young A., Koduri G. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007; 21 (5): 907-27.